Clinical Significance of a Large Difference (>= 2 points) between Biopsy and Post-prostatectomy Pathological Gleason Scores in Patients with Prostate Cancer
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q3
- 저널
- JOURNAL OF KOREAN MEDICAL SCIENCE26(4) · pp.507 · 2011
- 피인용
- Web of Science 4KCI 0
- JCR IF
- JCR 2010 0.834
- ISSN
- 1011-8934
저자
- 유창희제1저자한림대학교
- 오철영한림대학교
- 조진선한림대학교
- 송채린울산대학교
- 서성일성균관대학교
- 안한종울산대학교
- 황태곤가톨릭대학교
- 천준고려대학교
- 이강현국립암센터
- 권태균경북대학교
- 정태영서울보훈병원
- 정문기부산대학교
- 이상은서울대학교
- 이현무성균관대학교
- 이은식서울대학교
- 최영득연세대학교
- 정병하연세대학교
- 김형진전북대학교
- 김원재충북대학교
- 변석수서울보훈병원
- 최한용성균관대학교
초록
We investigated the clinical significance of large difference (>= points) between biopsy-derived (bGS) and post-prostatectomy Gleason scores (pGS). At 14 medical centers in Korea, 1,582 men who underwent radical prostatectomy for prostate cancer were included. According to the difference between bGS and pGS, the patients were divided into three groups: A (decreased in pGS >= 2, n = 30), B (changed in pGS <= n = 1,361; control group), and C (increased in pGS >= n = 55). We evaluated various clinicopathological factors of prostate cancer and hazards for biochemical failure. Group A showed significantly higher mean maximal percentage of cancer in the positive cores (max%) and pathological T stage than control. In group C, the number of biopsy core was significantly smaller, however, tumor volume and max% were significantly higher and more positive biopsy cores were presented than control. Worse pathological stage and more margin-positive were observed in group A and C than in control. Hazard ratio for biochemical failure was also higher in group A and C (P = 0.001). However, the groups were not independent factors in multivariate analysis. In conclusion, large difference between bGS and pGS shows poor prognosis even in the decreased group. However it is not an independent prognostic factor for biochemical failure.
키워드
Prostatic NeoplasmsGleason ScorePrognosisRADICAL PROSTATECTOMYSPECIMENSGRADEPROGRESSIONHETEROGENEITYPREDICTIONCARCINOMA
식별자
- WoS UID
- 000289534200006
- KCI
- ART001542938



로그인
연구물 목록으로